+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Lateral Flow Assays - Global Market Trajectory & Analytics

  • PDF Icon

    Report

  • 461 Pages
  • July 2022
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4805627

Global Lateral Flow Assays Market to Reach $11.2 Billion by 2026


Lateral flow assays are assays designed to effectively identify compounds of interest present in complex mixtures within 5-30 minutes. Lateral flow technology is fast emerging as a technique of choice for testing of infectious diseases given the numerous benefits the technology offers. The market expansion is attributed to high incidence of infectious conditions coupled with growing geriatric population, and increasing trend of point-of-care testing. The market is anticipated to also benefit from increasing popularity of self-diagnosis, a prominent trend that is propelling the demand for home-based lateral flow assay devices. Another factor bolstering the market growth is continuing technological advancements associated with lateral flow assays. These efforts are intended to improve these assays on the basis of selectivity, sensitivity and quantification. In addition, the integration of advanced quantification systems, new labels and simultaneous detection techniques is boosting growth. The COVID-19 pandemic has presented an ideal growth opportunity for lateral flow assays due to robust demand for lateral flow assay-based screening tests.

Amid the COVID-19 crisis, the global market for Lateral Flow Assays estimated at US$9.4 Billion in the year 2022, is projected to reach a revised size of US$11.2 Billion by 2026, growing at a CAGR of 5.9% over the analysis period. Kits & Reagents, one of the segments analyzed in the report, is projected to grow at a 6.1% CAGR to reach US$9.6 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Lateral Flow Readers segment is readjusted to a revised 4.9% CAGR for the next 7-year period. This segment currently accounts for a 17.9% share of the global Lateral Flow Assays market. The onset of COVID-19 outbreak during the end of 2019 created a pressing requirement of rapid diagnosis and identification of people with the infection. These tests gained considerable attention in various countries for screening patients and supporting efforts to curtain spread of the virus. In contrast to laboratory-based tests that are time-intensive, lateral flow test kits are portable, convenient to use, and require minimal training. These benefits provide extended use of these tests beyond healthcare facilities in low- to middle-income nations.

The U.S. Market is Estimated at $3.6 Billion in 2022, While China is Forecast to Reach $872.4 Million by 2026


The Lateral Flow Assays market in the U.S. is estimated at US$3.6 Billion in the year 2022. The country currently accounts for a 38.64% share in the global market. China, the world's second largest economy, is forecast to reach an estimated market size of US$872.4 Million in the year 2026 trailing a CAGR of 8.8% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.8% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR while Rest of European market (as defined in the study) will reach US$917 Million by the end of the analysis period. The US market is at the forefront of adoption of lateral flow assays supported by rising prevalence of infectious conditions like tuberculosis and Lyme disease along with increasing mortality rate linked with AIDS. Growth is further bolstered by the mayhem created by the COVID-19 pandemic, prompting governments to make aggressive attempts toward mass screening programs. A host of factors are contributing to rapid uptake of lateral flow assays in developing regions, especially Asia-Pacific. While demand for these products is primarily being driven by growing healthcare expenditure and increased demand for diagnostics, other factors including rising healthcare awareness and subsequent increase in demand for healthcare services are also contributing to demand increase.

Select Competitors (Total 55 Featured):

  • ABBOTT Laboratories
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Hologic Inc.
  • Merck KGaA
  • PerkinElmer Inc.
  • QIAGEN N.V.
  • Quidel Corporation
  • Siemens AG

What`s New for 2022?

  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to the digital archives
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Impact of Covid-19 and a Looming Global Recession
  • World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
  • Challenges and Opportunities for Clinical Diagnostics amid the Pandemic
  • Impact of COVID-19 on Lateral Flow Assays Market
  • Performance Analysis of COVID-19 Tests
  • COVID-19 Cases Worldwide by Country: As on May 17, 2021
  • Lateral Flow Assay-based Tests Soar into Spotlight during COVID-19 Pandemic
  • LFAS Arms Nations to Battle the Coronavirus
  • Lateral Flow Assays - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • GLOBAL MARKET OVERVIEW
  • A Prelude to Lateral Flow Technology
  • Lateral Flow Assays: An Introduction
  • Lateral Flow Assays: A Mighty, Paper-based Diagnostics Approach
  • Lateral Flow Assays Market Appears Poised to Experience Uninterrupted Flow Ahead
  • Clinical Testing Remains Primary Application Segment of Lateral Flow Assays Market
  • Rising Incidence of Infectious Conditions Ignite Demand
  • LFA Overcomes Testing Barriers
  • Emerging Applications Present Lucrative Opportunities
  • The US Retains Leadership Tag in Global Lateral Flow Assays Market
  • Competitive Scenario
  • Market Outlook
  • RECENT MARKET ACTIVITY
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Growing Incidence of Infectious Diseases to Drive LFA Market
  • Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %)
  • Global Malaria Case Incidence Rate (per 1,000 population) for the Years 2015, 2016, 2017 & 2018
  • Global TB Cases (In Millions) Reported to Have Been Treated for the Years 2015-2019
  • Greater Number of Tests for HIV and Sexually Transmitted Diseases Amplify Growth
  • Global HIV Prevalence: Number of People Living with AIDs (in Thousands) by Region for 2018
  • Number of AIDS-Related Deaths (in Thousands) by Region for 2018
  • Rapid HIV Tests: A New Age Diagnostic Weapon against the Killer Disease
  • Home HIV Testing Emerges as a Lucrative Option
  • Viral Hepatitis Testing Presents Opportunities for Lateral Flow Assays Market
  • Hepatitis B prevalence Worldwide by Region
  • Uptrend in Healthcare Spending Creates Fertile Environment
  • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
  • Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
  • Ageing Demographics to Drive Demand
  • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
  • Self-Diagnosis Emerge as Notable Trend
  • New Approvals of Self-Test Devices to Give a Boost to the Market
  • Lateral Flow Assays Hold Rosy Outlook with Emerging Applications Areas
  • LFAs Gains Foothold in Multiplexing
  • Multiplexed Point-Of-Care Testing
  • Remote Healthcare Benefits Lateral Flow Assays Market
  • Lateral Flow Assays to Become Landmark Approach in Precision Diagnostics
  • Lateral Flow Assays & Precision Diagnostics
  • Digitalization of Lateral Flows to Support Healthcare
  • Digitalized Lateral Flow Assays: An Exciting Platform to Change Data-Driven Healthcare Domain
  • Lateral Flow Assays Emerge as Integral Components of Food Safety & Environmental Testing
  • Novel Lateral Flow Assay Marks Shift from Reactive to Proactive Food Safety Testing Approach
  • Technological Advancements Remain Crucial to Future Growth
  • Researchers Develop Novel Technique to Significantly Increase Accuracy of Lateral Flow Tests
  • Smartphone-based Fully-Quantitative Lateral Flow Assay Analyzer for Reliable & Quick Diagnosis
  • Innovative Lateral Flow Immunoassays Find Increasing Role in Detection of Dengue & Zika Virus
  • Abingdon Health Introduced ADxLR5® Developer for Assay Development
  • Rapid Tests Connectivity with Wireless Data Platforms
  • Miniaturization of Analytical Instruments Presents Lucrative Opportunities for Handheld Lateral Flow Assay Readers
  • Low Accuracy Remains a Major Restraint
  • Limited Reimbursement & Raw Material Supply Issues as Key Challenges
4. GLOBAL MARKET PERSPECTIVEIII. MARKET ANALYSIS
UNITED STATES
  • Lateral Flow Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
CANADA
JAPAN
  • Lateral Flow Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
CHINA
  • Lateral Flow Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
EUROPE
  • Lateral Flow Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
FRANCE
  • Lateral Flow Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
GERMANY
  • Lateral Flow Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
ITALY
UNITED KINGDOM
  • Lateral Flow Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Lateral Flow Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
AUSTRALIA
  • Lateral Flow Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
INDIA
  • Lateral Flow Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Lateral Flow Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
BRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Lateral Flow Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
AFRICA
  • Lateral Flow Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
IV. COMPETITION
  • Total Companies Profiled: 55

Companies Mentioned

A selection of companies mentioned in this report includes:

  • ABBOTT Laboratories
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Hologic Inc.
  • Merck KGaA
  • PerkinElmer Inc.
  • QIAGEN N.V.
  • Quidel Corporation
  • Siemens AG